Hyaluronic acid skin fillers: Adverse reactions and skin testing - 02/09/11
Correspondence: Nicholas J. Lowe, MD, Cranley Clinic, 3 Harcourt House, 19a Cavendish Square, London, W1M 9AD, UK.
Abstract |
Background: Hyaluronic acid (HA) fillers have been proposed as alternatives to other temporary skin fillers, such as bovine collagen, for treating facial skin lines and for providing lip augmentation. Several types of commercial HA fillers are now available in many countries. They include Restylane, which is produced by microbiologic engineering techniques, and Hylaform, which is HA extract derived from rooster combs. They have been approved for use in several countries, but not currently in the United States. There are no recommendations to perform pretreatment skin testing by the manufacturers. Objective: Our purpose is to describe and comment on our experiences with Hylaform and Restylane fillers. Observation of any side effects and skin testing results were documented. Methods: Between September 1996 and September 2000, 709 patients were treated with Hylaform and Restylane and were followed up clinically for at least 1 year. Three of these patients (0.42%) developed delayed skin reactions. Three other patients were referred for evaluation of their skin reactions from other practitioners. Five of these 6 patients agreed to skin testing of their forearms. Results: In the 5 patients tested, challenge intradermal skin testing was positive in 4 patients; the reactions started approximately 8 weeks after injection. Conclusions: There was a slight incidence of delayed inflammatory skin reactions to two HA fillers. Both of these reactions occurred after the first and repeat injections. Challenge skin testing was positive in 4 of 5 tested patients. (J Am Acad Dermatol 2001;45:930-3.)
Le texte complet de cet article est disponible en PDF.Plan
Dr Lowe is the recipient of a research grant and consultant payments from Biomatrix, manufacturers of Hylaform. |
|
Reprints not available from authors. |
Vol 45 - N° 6
P. 930-933 - décembre 2001 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?